SOLCERA® Solution is a targeted 5% potassium hydroxide topical skin solution developed for the external treatment of actinic keratosis (solar keratosis) in adults with an intact immune system.

It is specially used on rough, scaly, sun-damaged skin lesions that develop on chronically UV-exposed areas such as the face, scalp, ears, forearms, and hands. The included special disposable applicators allow precise application directly onto affected lesions.

Exact Ingredients

Per 1 ml solution:

• Potassium hydroxide – 50 mg

• Purified water

Strength: 5% potassium hydroxide solution

Key Benefits

• Targeted treatment for actinic keratosis

• Helps remove rough, sun-damaged keratotic lesions

• Precision disposable applicators included

• Easy topical spot application

• Suitable for dermatologist-confirmed solar keratoses

• Compact 4 ml treatment bottle

• Commonly used on UV-damaged skin areas

Indications

Recommended for:

• Actinic keratosis

• Solar keratosis

• Sun-damaged rough skin lesions

• Precancerous UV-related keratotic plaques

• Scaly lesions on face, scalp, ears, and hands

Directions for Use

• Apply using the included special disposable applicator

• Use 2 times daily

• In thicker lesions, a physician may advise 3 times daily

• Apply only to the affected lesion

• Use on dry skin

• Avoid healthy surrounding skin

• Continue exactly as directed by the package insert or dermatologist

Product Details

• Brand: InfectoPharm

• Product Name: SOLCERA®

• Form: Topical skin solution

• Strength: 5% potassium hydroxide

• Pack Size: 4 ml

• Category: Actinic keratosis topical treatment

• Includes: 100 disposable special applicators

Precautions

• For external skin use only

• Corrosive alkaline solution — avoid eyes and mucous membranes

• Do not apply to healthy skin, open wounds, or irritated skin

• Not for use in children or adolescents under 18

• Wash hands after application

• Stop and consult a dermatologist if severe irritation develops

Important Disclaimer

This product is intended for the topical treatment of physician-confirmed actinic keratosis. Because lesions may be precancerous, persistent, changing, or recurrent skin spots require dermatologic evaluation.